Get the latest Science News and Discoveries
Moffitt researchers discover new therapeutic target for non-small cell lung cancer - EurekAlert
A new Moffitt Cancer Center study published in the journal Immunity offers insight into how lung cancer cells evade the protective immune system, potentially opening a door for novel antibody-based immunotherapies. Their study centers on a molecule called Jagged2, which plays a primary role in fueling the aggressiveness and immune evasion capacity of lung cancer.
None
Or read this on Eureka Alert